WebJan 15, 2024 · (Reuters) - Thermo Fisher Scientific Inc said on Friday it completed its 725 million euros ($879.72 million) acquisition of Belgium-based Henogen SA that will help … WebJan 15, 2024 · Buoyed by revenues from COVID-19 testing over the past year, Thermo Fisher announced that it has now acquired Henogen, Novasep's viral vector manufacturing division, for about €725 million or ...
Thermo Fisher Shells Out $876M For Viral Vector Maker
WebJan 15, 2024 · Thermo Fisher closes Henogen acquisition By The Science Advisory Board staff writers. January 15, 2024-- Thermo Fisher Scientific has closed its acquisition of Groupe Novasep's Henogen, a viral vector manufacturing business in Belgium, for approximately 725 million euros ($876 million U.S.) in cash. WebJan 19, 2024 · French-based CDMO Novasep has announced two sales. Henagen, its Belgium-based viral vectors operation, has been sold to Thermo Fisher Scientific for about €725 million, while, in a much smaller deal, it also intends to sell its chromatography equipment division to Sartorius Stedim Biotech. citizen security life insurance company
Thermo Fisher strikes again in viral vectors - Chemical
WebJan 5, 2024 · WALTHAM, Mass., Jan. 5, 2024 / PRNewswire / -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2024 for a total cash purchase price of … WebJan 15, 2024 · Novasep was founded more than 20 years ago. It had about 400 employees. Estimated 2024 revenue was about $95 million. “Thermo Fisher is an outstanding partner … WebJan 15, 2024 · WALTHAM, Mass. and LYON, France, Jan. 15, 2024 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading... citizens edmond bank